Resistance to β-lactams among blood isolates of Salmonella spp. in European hospitals: Results from the SENTRY Antimicrobial Surveillance Program 1997-98

Clinical Microbiology and Infection

Volumn 9, Issue 2, 2003, Pages 149-152

  Tzouvelekis, L S ^a   Lukova, V ^a   Tassios, P T ^a   Fluit, A C ^b   Jones, R N ^c   Legakis, N J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Resistance; Salmonella; lactams

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; PENICILLIN G; PENICILLINASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIMENTIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BLOOD ANALYSIS; CONJUGATION; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; ENZYME SYNTHESIS; EUROPE; NONHUMAN; PENICILLIN RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; SALMONELLA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM;

EID: 0038076277     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00507.x     Document Type: Article

References (10)

1. Llanes C, Kirchgesner V, Plesiat P. Propagation of TEM- and PSE-type β-lactamases among amoxicillin-resistant Salmonella spp. isolated in France. Antimicrob Agents Chemother 1999; 43: 2430-6.
2. Poirel L, Guibert M, Bellais S, Naas T, Nordmann P. Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica sero-type Typhimurium DT104 from French patients. Antimicrob Agents Chemother 1999; 43: 1098-104.
3. Threlfall EJ, Frost JA, Ward LR, Rowe B. Increasing spectrum of resistance in multiresistant Salmonella typhimurium. Lancet 1996; 347: 1053-4.
4. Tassios PT, Gazouli M, Tzelepi E et al. Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries. J Clin Microbiol 1999; 37: 3774-7.
5. Fluit AC, Schmitz F-J, Verhoef J, the European SENTRY Participant Group. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients. Eur J Clin Microbiol Infect Dis 2001; 20: 188-91.
6. Fluit AC, Jones ME, Schmitz F-J et al. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY Antimicrobial Surveillance Program, 1997 and 1998. Clin Infect Dis 2000; 30: 454-60.
7. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th edn. Approved standard M7-A4. Villanova, Pa: NCCLS, 1997.
8. Espinasse F, Gheorghiu. R, Poiata A, Labia R, Nicolas-Chanoine MH. Reduced susceptibility to co-amoxiclav in Escherichia coli, Salmonella typhimurium and Klebsiella pneumoniae isolated in Romania between 1985 and 1993. J Antimicrob Chemother 1997; 39: 103-6.
9. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-84.
10. O Gallardo F, Ruiz J, Marco F, Towner Kj, Villa J. Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance. J Med Microbiol 1999; 48: 367-74.